BUSTED: Aegerion CEO caught doing some fast-talking on 'Fast Money'
This article was originally published in Scrip
Executive Summary
Aegerion Pharmaceuticals CEO Marc Beer learned one thing very clear last week: FDA officials apparently watch CNBC, specifically, the network's financial stock trading program Fast Money.
You may also be interested in...
Better Together? Aegerion And QLT Merge To Solve Problems
Aegerion and QLT will unite to create a new company dubbed Novelion in a deal that could help both companies solve some long-standing issues.
Moderna's Valera Takes mRNA Approach To Combat Zika
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan's Price Reform Pledge: Will Others Follow?
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.